206 related articles for article (PubMed ID: 2123786)
1. Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody.
McLigeyo SO; Notghi A; Anderton JL; Dick J
East Afr Med J; 1990 Sep; 67(9):667-73. PubMed ID: 2123786
[TBL] [Abstract][Full Text] [Related]
2. Orthoclone OKT3 treatment of acute renal allograft rejection in patients receiving maintenance cyclosporine therapy.
Hirsch RL; Layton PC; Barnes LA; Kremer AB; Goldstein G
Transplant Proc; 1987 Apr; 19(2 Suppl 1):32-6. PubMed ID: 3105138
[No Abstract] [Full Text] [Related]
3. Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.
Monaco A; Goldstein G; Barnes L
Transplant Proc; 1987 Apr; 19(2 Suppl 1):28-31. PubMed ID: 3105137
[No Abstract] [Full Text] [Related]
4. Orthoclone OKT3 treatment of acute renal allograft rejection.
Friedman J; Barnes L; Sheahan M; Tsai H; Goldstein G
Transplant Proc; 1987 Apr; 19(2 Suppl 2):46. PubMed ID: 3105144
[No Abstract] [Full Text] [Related]
5. Orthoclone OKT3 as rescue treatment for steroid-resistant and recurrent acute rejection in clinical renal transplantation.
Tvedegaard E; Olgaard K
Transplant Proc; 1990 Feb; 22(1):217-8. PubMed ID: 2106738
[No Abstract] [Full Text] [Related]
6. Treatment with OKT3 and cyclosporine for acute allograft rejection.
Schulak JA; Mayes JT; Hricik DE
Transplant Proc; 1991 Aug; 23(4):2119-22. PubMed ID: 1908150
[TBL] [Abstract][Full Text] [Related]
7. Orthoclone OKT3 as first-line therapy in acute renal allograft rejection.
Strate M; Jørgensen KA; Rohr N; Elbirk A; Svendsen V; Birkeland SA
Transplant Proc; 1990 Feb; 22(1):219-20. PubMed ID: 2106739
[No Abstract] [Full Text] [Related]
8. [Neurologic complications induced by the treatment of the acute renal allograft rejection with the monoclonal antibody OKT3].
Fernández O; Romero F; Bravo M; Burgos D; Cabello M; González-Molina M
Neurologia; 1993 Oct; 8(8):277-80. PubMed ID: 8240843
[TBL] [Abstract][Full Text] [Related]
9. Sparing of first dose effect of monovalent anti-CD3 antibody used in allograft rejection is associated with diminished release of pro-inflammatory cytokines.
Abbs IC; Clark M; Waldmann H; Chatenoud L; Koffman CG; Sacks SH
Ther Immunol; 1994 Dec; 1(6):325-31. PubMed ID: 7584508
[TBL] [Abstract][Full Text] [Related]
10. Use of Orthoclone OKT3 as treatment of acute renal allograft rejection and as first-line therapy in kidney transplantation.
Winde G; Dietl KH; Raidt H; Buchholz B; Lison AE; Bünte H
Transplant Proc; 1988 Oct; 20(5 Suppl 6):87-9. PubMed ID: 3140453
[No Abstract] [Full Text] [Related]
11. Monoclonal antibody (OKT3) rescue in refractory acute renal allograft rejection: report of 3 cases.
Suvanapha R; Laorpatanaskul S; Vajaraphongse R; Kitisin P; Srivatanawongsa V; Mulikamas S; Vajaraphongse K; Boonvisut S; Chusil S; Panmuong W
J Med Assoc Thai; 1989 Dec; 72(12):708-13. PubMed ID: 2628539
[TBL] [Abstract][Full Text] [Related]
12. Fibrinoid necrosis of a temporal artery complicating the treatment of refractory cardiac allograft rejection with murine monoclonal CD3 antibody (OKT3).
Hammond EH; Watson FS; Bristow MR; O'Connell JB; Gilbert EM; Doty DB; Renlund DG
J Heart Transplant; 1990; 9(3 Pt 1):236-8. PubMed ID: 2113090
[TBL] [Abstract][Full Text] [Related]
13. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
Widmer U; Frei D; Keusch G; Burger HR; Largiader F; Binswanger U
Transplant Proc; 1988 Oct; 20(5 Suppl 6):90-5. PubMed ID: 3140454
[No Abstract] [Full Text] [Related]
14. Clinical experience with Muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation.
Macris MP; Frazier OH; Lammermeier D; Radovancevic B; Duncan JM
J Heart Transplant; 1989; 8(4):281-7. PubMed ID: 2504894
[TBL] [Abstract][Full Text] [Related]
15. OKT 3: nursing considerations for use in acute renal transplant rejection.
Trusler LA
ANNA J; 1990 Aug; 17(4):299-303. PubMed ID: 2118750
[TBL] [Abstract][Full Text] [Related]
16. First and second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection followed by testing for anti-OKT3 IgM and/or IgG immunization.
Birkeland SA; Bach JF; Chatenoud L; Jørgensen KA; Strate M; Elbirk A; Rohr N; Svendsen V
Transplant Proc; 1990 Feb; 22(1):221-2. PubMed ID: 2106740
[No Abstract] [Full Text] [Related]
17. Reversal of steroid- and antithymocyte globulin-resistant acute rejection crises in renal transplantation with monoclonal antibody (OKT3).
Prieto C; Rodriguez-Paternina E; Andrés A; Morales JM; Farias J; Montoyo C; Regueiro JR; Rodicio JL
Transplant Proc; 1990 Aug; 22(4):1753-4. PubMed ID: 2117798
[No Abstract] [Full Text] [Related]
18. Reversing cardiac transplant rejection with Orthoclone OKT3.
Dault LA; Nagy CS; Collins JA
Am J Nurs; 1989 Jul; 89(7):953-5. PubMed ID: 2500020
[No Abstract] [Full Text] [Related]
19. Use of Orthoclone OKT3 monoclonal antibody in cardiac transplantation: early experience with rejection prophylaxis and treatment of refractory rejection.
Gilbert EM; Eiswirth CC; Renlund DG; Menlove RL; DeWitt CW; Freedman LA; Herrick CM; Gay WA; Bristow MR
Transplant Proc; 1987 Apr; 19(2 Suppl 1):45-53. PubMed ID: 3105140
[No Abstract] [Full Text] [Related]
20. Orthoclone OKT3 monoclonal antibody reversal of hepatic and cardiac allograft rejection unresponsive to conventional immunosuppressive treatments.
Kremer AB; Barnes L; Hirsch RL; Goldstein G
Transplant Proc; 1987 Apr; 19(2 Suppl 1):54-7. PubMed ID: 3105141
[No Abstract] [Full Text] [Related]
[Next] [New Search]